Biotech · Private company
Teva Branded Pharmaceutical Products R&D, Inc.
Track this companyFree. Adds Teva Branded Pharmaceutical Products R&D, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials2514 recruiting or active
Pipeline programs24From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline24
- ABSPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Albuterol sulfatePhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- FPPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Fp/ABSPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- FremanezumabPhase 3 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- TEV-56248Phase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- TV-44749Phase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- DaratumumabPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Modakafusp AlfaPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- TEV-48574Phase 2 · Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TEV-48574 Dose Regimen APhase 2 · Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TEV-48574 Dose Regiment BPhase 2 · Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TEV-53408Phase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TEV-56286Phase 2 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- Fp MDPIPhase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TEV-53408Phase 1 · VitiligoClinicalTrials.gov · fetched Nov 12, 2026
- TEV-56278Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TEV-56286Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- TEV-56286 ReferencePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- TEV-56286 TestPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- albuterolAsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Albuterol eMDPI DSAsthmaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis SuppurativaPHASE2 · RECRUITING · started Oct 19, 2026ClinicalTrials.gov NCT07812116 · fetched Nov 12, 2026
- A Trial to Assess TEV-56286 at Different Doses in Healthy ParticipantsPHASE1 · RECRUITING · started Jun 26, 2026ClinicalTrials.gov NCT07674940 · fetched Nov 12, 2026
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseasePHASE3 · RECRUITING · started Jan 22, 2026ClinicalTrials.gov NCT07184944 · fetched Nov 12, 2026
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisPHASE3 · RECRUITING · started Jan 16, 2026ClinicalTrials.gov NCT07185009 · fetched Nov 12, 2026
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisPHASE3 · RECRUITING · started Oct 8, 2025ClinicalTrials.gov NCT07184996 · fetched Nov 12, 2026
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseasePHASE3 · RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT07184931 · fetched Nov 12, 2026
- An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyPHASE2 · RECRUITING · started Sep 30, 2025ClinicalTrials.gov NCT07197866 · fetched Nov 12, 2026
- A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Mar 31, 2025ClinicalTrials.gov NCT06807463 · fetched Nov 12, 2026
- A Study to Assess New Formulations of TEV-56286PHASE1 · COMPLETED · started Mar 10, 2025ClinicalTrials.gov NCT06911567 · fetched Nov 12, 2026
- A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPHASE3 · COMPLETED · started Dec 12, 2024ClinicalTrials.gov NCT06664619 · fetched Nov 12, 2026
- A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoPHASE1 · RECRUITING · started Nov 11, 2024ClinicalTrials.gov NCT06625177 · fetched Nov 12, 2026
- A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 2, 2024ClinicalTrials.gov NCT06568237 · fetched Nov 12, 2026
- An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jul 22, 2024ClinicalTrials.gov NCT06480552 · fetched Nov 12, 2026
- Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldPHASE1 · COMPLETED · started May 16, 2024ClinicalTrials.gov NCT06290102 · fetched Nov 12, 2026
- A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 30, 2023ClinicalTrials.gov NCT06052267 · fetched Nov 12, 2026
- A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaPHASE3 · COMPLETED · started Jan 24, 2023ClinicalTrials.gov NCT05693935 · fetched Nov 12, 2026
- A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple MyelomaPHASE1_PHASE2 · TERMINATED · started Jan 23, 2023ClinicalTrials.gov NCT05590377 · fetched Nov 12, 2026
- A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Jan 11, 2023ClinicalTrials.gov NCT05668013 · fetched Nov 12, 2026
- A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseasePHASE2 · COMPLETED · started Sep 30, 2022ClinicalTrials.gov NCT05499130 · fetched Nov 12, 2026
- Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington DiseasePHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 19, 2021ClinicalTrials.gov NCT04713982 · fetched Nov 12, 2026
- A Study to Test if TVB-009P is Effective in Relieving Postmenopausal OsteoporosisPHASE3 · COMPLETED · started Mar 22, 2021ClinicalTrials.gov NCT04729621 · fetched Nov 12, 2026
- A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With AsthmaPHASE4 · COMPLETED · started Oct 26, 2020ClinicalTrials.gov NCT03890666 · fetched Nov 12, 2026
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsPHASE3 · COMPLETED · started Sep 16, 2020ClinicalTrials.gov NCT04530110 · fetched Nov 12, 2026
- A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgePHASE3 · COMPLETED · started Jul 15, 2020ClinicalTrials.gov NCT04458857 · fetched Nov 12, 2026
- A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple MyelomaPHASE1_PHASE2 · TERMINATED · started Oct 4, 2017ClinicalTrials.gov NCT03215030 · fetched Nov 12, 2026